Can-Fite Biopharma Ltd Sponsored ADR (Israel) (CANF): Price and Financial Metrics

Can-Fite Biopharma Ltd Sponsored ADR (Israel) (CANF): $2.01

0.02 (-0.99%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

D

Add CANF to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#193 of 332

in industry

CANF Price/Volume Stats

Current price $2.01 52-week high $4.69
Prev. close $2.03 52-week low $1.83
Day low $1.90 Volume 95,500
Day high $2.09 Avg. volume 67,859
50-day MA $2.24 Dividend yield N/A
200-day MA $2.41 Market Cap 7.12M

CANF Stock Price Chart Interactive Chart >


Can-Fite Biopharma Ltd Sponsored ADR (Israel) (CANF) Company Bio


Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver and inflammatory disease, and sexual dysfunction. The company's lead drug candidate CF101 (Piclidenoson), which is in Phase III clinical trial for the treatment of rheumatoid arthritis and psoriasis. It also develops CF102 (Namodenoson) that is completed Phase II clinical trial for the treatment of hepatocellular carcinoma, as well as in Phase II trial for the treatment of non-alcoholic steatohepatitis; and CF602, which is in pre-clinical trial for the treatment of erectile dysfunction. Can-Fite BioPharma Ltd. has collaboration agreement with CMS Medical to develop, manufacture, and commercialize Piclidenoson and Namodenoson; and Univo Pharmaceuticals to identify and co-develop specific formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. The company was formerly known as Can-Fite Technologies Ltd. and changed its name to Can-Fite BioPharma Ltd. in January 2001. Can-Fite BioPharma Ltd. was founded in 1994 and is headquartered in Petah-Tikva, Israel.


CANF Latest News Stream


Event/Time News Detail
Loading, please wait...

CANF Latest Social Stream


Loading social stream, please wait...

View Full CANF Social Stream

CANF Price Returns

1-mo -28.72%
3-mo -15.19%
6-mo -18.62%
1-year -4.66%
3-year -83.11%
5-year -92.42%
YTD -8.64%
2023 -64.11%
2022 -52.48%
2021 -27.53%
2020 -46.06%
2019 -82.54%

Continue Researching CANF

Want to see what other sources are saying about Can-Fite BioPharma Ltd's financials and stock price? Try the links below:

Can-Fite BioPharma Ltd (CANF) Stock Price | Nasdaq
Can-Fite BioPharma Ltd (CANF) Stock Quote, History and News - Yahoo Finance
Can-Fite BioPharma Ltd (CANF) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!